Genomics BioSci & Tech. Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 191.7 million compared to TWD 205.22 million a year ago.

Net loss was TWD 78.3 million compared to net income of TWD 67.91 million a year ago. Basic loss per share from continuing operations was TWD 1.15 compared to basic earnings per share from continuing operations of TWD 1.0861 a year ago. Diluted loss per share from continuing operations was TWD 1.15 compared to diluted earnings per share from continuing operations of TWD 1.0861 a year ago.